Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BioNexus Gene Lab Corp ( (BGLC) ) has shared an announcement.
BioNexus Gene Lab Corp. has appointed Ms. Chong Set Fui as the new Chief Financial Officer and Principal Financial Officer, effective June 17, 2025. With over 25 years of financial leadership experience, Ms. Chong will also serve as CFO of the company’s subsidiary, MRNA Scientific Sdn. Bhd. This strategic appointment, recommended by the Nomination and Corporate Governance Committee, marks a significant step in strengthening the company’s financial oversight and compliance with U.S. federal securities laws and Nasdaq rules.
More about BioNexus Gene Lab Corp
Average Trading Volume: 670,542
Technical Sentiment Signal: Sell
Current Market Cap: $5.16M
For detailed information about BGLC stock, go to TipRanks’ Stock Analysis page.